Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ALBANY MOLECULAR RESH INC Financial Overview

  • Income Statement: AMRI
      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 229.26 M 192.51 M 36.75 M 16.03%
    Gross Profit 83.18 M 60.48 M 22.71 M 27.30%
    Net Income Before Extra Items/Preferred Div 20.56 M 8.94 M 11.62 M 56.54%
    Operating Income 27.79 M 11.62 M 16.17 M 58.18%
    View Full Report

  • Cash Flow: AMRI
      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -18.61 M -3.00 M -15.62 M 83.90%
    Net Cash Flow - Investing -8.98 M 9.78 M -18.76 M 208.99%
    Net Cash Flow/Operating Activities 26.54 M 31.67 M -5.13 M -19.32%
    View Full Report

  • Balance Sheet: AMRI

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 390.68 M 386.65 M 4.03 M 1.03%
    Total Liabilities 64.00 M 52.09 M 11.92 M 18.62%
    Shareholders Equity 326.68 M 334.57 M -7.89 M -2.41%
    View Full Report

  • Key Ratios / Statistics: AMRI

    • Valuation

      Price/Earnings (TTM) 14.98
      Price/Sales (TTM) 1.34
      Price/Book (MRQ) 0.80
      Price/Cash Flow (TTM) 7.15

    • Profitability

      Gross Margin 36.28
      Operating Margin 12.12
      Profit Margin 8.97

    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00

    • Financial Strength

      Quick Ratio (MRQ) 3.93
      Current Ratio (MRQ) 5.41
      Long Term Debt-to-Equity (MRQ) 3.99

    • Management Effectiveness

      Return on Equity (TTM) 6.35
      Return on Assets (TTM) 5.37
      Return on Investments (TTM) 6.06
    View All Key Ratios